Do you lose weight in the first month of Wegovy?

The 0.25mg starting dose is a settling-in phase — appetite effects deepen as the dose increases over several months.
In the STEP 1 clinical trial, average weight loss across 68 weeks was around 15% of body weight at the 2.4mg maintenance dose.
Early losses of 1–3 kg in the first four weeks are common; some people see less, a few see more, both are normal.
Side effects (mainly nausea and digestive changes) peak early and often settle within days to two weeks, which is why the slow titration schedule matters.

Most people do see some weight loss in their first month on Wegovy, though the amount varies and the early weeks are primarily about tolerability, not maximum effect. The 0.25mg starting dose is intentionally gentle — your body is adjusting, appetite suppression builds gradually, and meaningful loss typically follows over months, not days. Wegovy (semaglutide) is a prescription-only medicine; a prescriber assesses whether it is clinically appropriate before treatment begins.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What actually happens, week by week, in your first month on Wegovy

Step 1: The first injection and the first two weeks

Your first pen delivers 0.25mg of semaglutide once a week. This is not the dose at which most people experience significant appetite suppression, it exists to let your digestive system adapt without being overwhelmed. A question our prescribers hear most weeks is some version of: "I've had two injections and I'm not sure it's doing anything, is that normal?" For the majority of people, yes, it is.

The scale may move a little. Some people find they naturally eat slightly less simply because nausea makes large meals unappealing. Others notice almost no change in appetite at all. Nausea, constipation, and mild digestive discomfort are most common in this window and typically ease as the weeks pass, as the NHS's semaglutide medicines page explains. What this fortnight is really doing is laying the groundwork for what comes next.

Step 2: Weeks three and four, still on the starter dose, but patterns emerge

By weeks three and four, many people begin noticing the first real signals: meals feel satisfying sooner, the pull toward evening snacking quietens, portion sizes shrink naturally. The scale often follows, though not always as dramatically as people hope.

A realistic first-month figure for most people is somewhere between 1 and 3 kg, though this is not a clinical target, it is a rough description of what is commonly reported. Body weight fluctuates day to day with hydration, digestion and sodium intake, which is why weekly weigh-ins at the same time of day give a cleaner picture than daily readings. If you want a fuller account of what these early weeks look like, including the Wegovy first month results that people commonly report, our guide to the first month of Wegovy covers the experience in more detail.

The absence of dramatic loss at this stage does not mean the medicine is not working. It means it is doing exactly what it is designed to do: start gently.

Step 3: What the trial evidence tells us about the broader trajectory

The STEP 1 trial, published in the New England Journal of Medicine, followed adults with obesity over 68 weeks. At the 2.4mg maintenance dose, participants lost around 15% of their starting body weight on average, a figure that accumulated over many months, not in the opening weeks. The medicine's full effect builds as the dose titrates upward and the body responds.

This matters because the first month is genuinely not representative of what Wegovy does over time. People who feel underwhelmed by early results and stop treatment early miss the phase where the real work happens. Dose increases occur roughly every four weeks under prescriber guidance; each step tends to bring a deeper reduction in appetite. If you are curious about how the timeline unfolds beyond month one, how long Wegovy takes to work sets out the evidence-based picture clearly.

For context on what the private cost of treatment involves, our treatment overview page sets out everything that is included.

Step 4: Why individual variation is so wide in month one

Two people on the same dose, eating similar diets, can lose noticeably different amounts in month one. Several things drive this. Starting weight matters, a higher starting weight tends to produce larger absolute losses even at equivalent percentages. Sleep, stress, physical activity, and any medications that affect weight or fluid retention all play a role. Digestive side effects that reduce food intake early on can temporarily inflate initial figures, then level off as nausea settles.

Those who have previously tried semaglutide and found it less effective the second time may be responding to a different set of factors, there is specific information on Wegovy not working as well on a second course for anyone in that position.

The shape of the first month is also influenced by how closely someone follows the lifestyle advice that accompanies treatment. Adequate protein, regular hydration, and some physical activity all support the medicine's effects and help preserve muscle as weight falls. This is not about being perfect, it is about the cumulative effect of small, consistent changes.

If you want a clearer sense of what outcomes other people have seen by the end of month one, average first-month weight loss on Wegovy pulls together what the data and real-world reports show. And if the first week specifically is on your mind, what happens in the first week on Wegovy addresses that narrower window directly.

Wegovy is a prescription-only medicine. Whether it is right for you depends on a full clinical assessment, not a figure on a website. If you would like to speak with a prescriber and find out whether you are eligible, you are welcome to start your free consultation at any point.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions